The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. - Wikidata - wikimedia - TriplyDB

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

http://www.wikidata.org/entity/Q35012920

about

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy Best clinical practice in botulinum toxin treatment for children with cerebral palsy Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity activities in unilateral Cerebral Palsy: a clinical trial Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.Study protocol: precision of a protocol for manual intramuscular needle placement checked by passive stretching and relaxing of the target muscle in the lower extremity during BTX-A treatment in children with spastic cerebral palsy, as verified by m GRIN: "GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial": study protocol.Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.Influence of botulinum toxin therapy on postural control and lower limb intersegmental coordination in children with spastic cerebral palsy Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey Factors Influencing the Gross Motor Outcome of Intensive Therapy in Children with Cerebral Palsy and Developmental Delay.Botulinum toxin a injections to the upper limbs in children with cerebral palsy: duration of effect.Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin.Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Botulinum toxin A treatment of the lower extremities in children with cerebral palsy.Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives.Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.Childhood dystonias.The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy.AbobotulinumtoxinA (Dysport®) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy.Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.Reliability of retrospective assignment of gross motor function classification system scores.Functional electrical stimulation combined with botulinum toxin type A to improve hand function in children with spastic hemiparesis - a pilot study.Botulinum neurotoxin treatment in children with cerebral palsy: validation of a needle placement protocol using passive muscle stretching and relaxing.Patient-specific determinants of responsiveness to robot-enhanced treadmill therapy in children and adolescents with cerebral palsy.Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II.Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A.Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.Spread of Botulinum Neurotoxin Type A at Standard Doses Is Inherent to the Successful Treatment of Spastic Equinus Foot in Cerebral Palsy

P2860

Q28074809-17EEC3F7-54CE-4D15-BC0B-DE7773496C59 Q30652125-EB608868-8CAF-4C68-8311-2C8D54577B3D Q30661973-2114571B-4D62-48E2-A436-8802A3FB0037 Q34371274-153614FA-1CEE-4987-9817-29A4C9EE6C96 Q34966160-845A91A1-F664-459E-B5B3-698A5C1B6F98 Q35087305-C94B577B-CD02-4FFD-99E4-D7B5D6FE29B0 Q35155959-0A7A62C4-B99E-4CE8-A812-AD6802B4566D Q36329606-07B925F6-DAE3-4E31-B813-2069E0970068 Q36586751-22AA9364-4DDB-4AD2-B1FD-2BB378672AAD Q36993876-6CE5FD8B-C01D-428C-A1A3-78BA9A93F05B Q37627920-0085EBB9-271C-4397-8E90-65BEA8BE688F Q37632889-5D650DBA-0D62-45BB-8F32-19E1813CBAA9 Q37740501-CBF94B25-7C18-4C02-8F52-B09DEEE4AB81 Q37798600-4E8A17CB-4338-4BB4-9913-BA6406D74612 Q37801960-BADBD545-1B39-4934-96FA-C384CCCF70AD Q37835354-DB0ADDA5-45BC-4C47-8696-BFD672BC1AA9 Q37883035-B6AEF360-0732-4052-9D3C-3E56A0737AD1 Q37888668-75522742-C071-4B56-B6FA-790A7044B44E Q38178982-0C37F478-AE7B-4A01-A66B-63E54E49C86C Q38232157-078DF59C-6352-4826-8DB9-977F20715711 Q38245465-C33F9965-D42D-49DB-B468-C2981C7CE723 Q38303320-8D0DE79C-B0AA-40A4-BB7E-2F2AA79B7FB4 Q39036581-145C332F-AE46-4093-83E5-E27303BA28CA Q39639414-BCAF8894-41B8-472E-B3CB-824CDAFCCD88 Q42290456-B2358E7B-6D68-4F66-AF6E-9D5CB96E9D7F Q43890843-5830644F-C386-4264-A41C-CD836DF84305 Q44094718-5700D5A8-306C-4690-836F-6B06073A57D3 Q45790392-00C9E7F2-B17C-453C-AF3C-E7AF952FAA0E Q47412154-84D4FF8D-B501-4D72-978E-4F7011FDA1DD Q50638976-16187013-6284-44CC-8FE2-B7FED3A83B52 Q50764476-F895B63F-C165-47F1-85BE-547E7F69E82A Q53435455-D6F84FB2-6DF5-4F94-A83B-7F3614A62978 Q55039946-A8A16A34-DE6A-4B67-9930-8A954CAB1E50 Q56781220-5B259502-6302-47C7-B3A5-D24C4473618D

P2860

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

http://www.wikidata.org/entity/Q35012920

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The updated European Consensus ...... children with cerebral palsy.

@ast

The updated European Consensus ...... children with cerebral palsy.

@en

type

label

The updated European Consensus ...... children with cerebral palsy.

@ast

The updated European Consensus ...... children with cerebral palsy.

@en

prefLabel

The updated European Consensus ...... children with cerebral palsy.

@ast

The updated European Consensus ...... children with cerebral palsy.

@en

P1433

Q35012920-8E3A7944-ED55-4B1D-9733-C10D05419E90

P1476

Q35012920-B29CBDA1-A647-4489-8F3F-510982D0C236

P2093

Q35012920-112EC8BD-0523-4C59-A110-74D3B07DAB29

Q35012920-1745BB18-2387-40E0-9445-F00C241FF04D

Q35012920-205CDDED-5B63-403B-B57A-47AF40215B5F

Q35012920-2538546E-B699-4886-8B26-CBF9F34187B4

Q35012920-2748F084-FB66-4B67-8DDE-DF74D28507B0

Q35012920-279A44D0-8BFF-43B7-BF0A-A664BFE6007A

Q35012920-2A1D9D22-4268-42F0-AF0A-F5234519E6C2

Q35012920-31A37B78-E838-42A1-8827-FA147CCF55AA

Q35012920-3AB10A41-1010-4773-85AF-79ECBBA35466

Q35012920-47CD0898-E9F3-46BC-BB77-5F253DC4B57B

P304

Q35012920-79C97F5E-A7B5-4D3B-87D1-1B942EA6973C

P31

Q35012920-B00B8667-C7FC-4642-AFFA-5E6C5348C901

P356

Q35012920-727B5748-6F86-42F7-877B-9EAC4C17C097

P433

Q35012920-A7B16D92-E136-4D82-810D-62CDBF308A52

P478

Q35012920-650BD1D0-E856-495A-8704-83466AF985E2

P50

Q35012920-57EAFCBD-44AF-4D4A-A86D-0F2D3204E28C

Q35012920-741AF996-BC15-4AB2-8458-A38C76DCDEEF

Q35012920-84F959BB-A0F9-4669-95CD-EDF597E1E354

Q35012920-A96F8F27-AD74-4D92-851B-1E3B9D0277C1

Q35012920-E8F65309-69BB-4943-9B5F-FBA6A92E48D9

P577

Q35012920-4D6872DC-71FD-457B-9DCC-4DF5C9C91891

P5875

Q35012920-8E2B5D8B-362C-4793-89CB-A39E09C8CBAA

P698

Q35012920-C6CFA1DE-259C-4EED-99BB-F744513A5596

P356

J.EJPN.2009.09.005

P1433

European Journal of Paediatric Neurology

P1476

The updated European Consensus ...... r children with cerebral palsy

@en

P2093

Anne Renders

http://www.w3.org/2001/XMLSchema#string

Antigone Papavassiliou

http://www.w3.org/2001/XMLSchema#string

Anya van Campenhout

http://www.w3.org/2001/XMLSchema#string

Charlie Fairhurst

http://www.w3.org/2001/XMLSchema#string

Edith Morel

http://www.w3.org/2001/XMLSchema#string

Elisabeth Kolanowski

http://www.w3.org/2001/XMLSchema#string

Elke Viehweger

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Chaleat Valayer

http://www.w3.org/2001/XMLSchema#string

Florian Heinen

http://www.w3.org/2001/XMLSchema#string

Frank S Plasschaert

http://www.w3.org/2001/XMLSchema#string

P304

45-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJPN.2009.09.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Rémy-Néris

Kristina Tedroff

Kaat Desloovere

Samuel Ignacio Pascual

A Sebastian Schroeder

P577

2009-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38090085

http://www.w3.org/2001/XMLSchema#string

P698

19914110

http://www.w3.org/2001/XMLSchema#string